Vol. 23, No. 11, 2012
Dantas et al.
2063
tryptophan. This compound seems to have three excitation
peaks at 460, 525 and 560 nm and one emission peak close
to 605 nm (see Figure 6b, sample-8 h).
Another important conclusion is to show that the use
of different instrumental settings is important to enable the
visualization of fluorescence signals in the lower energy
spectral region due the wavelength dependent sensitivity
of the spectrofluorometer PMT.
4
1
Asamizu et al. reported the electronic absorption
spectra of StaD, an enzyme involved in saturosporine
biosynthesis that is a homolog to VioB and responsible
for the coupling reaction between two molecules of
Finally, this methodology has great potential to achieve
a deeper insight into the biosynthesis of natural products.
+
indole-3-pyruvic acid and NH4 to yield CPA. It has an
absorption maximum at 430 nm and smaller absorption
bands at 530 and 565 nm and presents an excitation spectra
similar to that of the fluorophore above described. This fact
probably indicates that other indolocarbazoles are being
produced during the cultivation.
Acknowledgments
The authors acknowledge Conselho Nacional de
Desenvolvimento Científico e Tecnológico (CNPq) for
financial support, Dorival Martins for his support with
C. violaceum and Prof Dr Carol H. Collins for English
revision.
The compound represented by the dashed red line in
Figures 7b shows a broad excitation band at 400-470 nm and
peak emission around 512 nm. The concentration profile
indicates that this fluorophore is produced during violacein
biosynthesis. Finally, in Figure 7b, the excitation profile
represented by the dotted red line with narrow maximum
centered at 575 nm and an emission maximum at 675 nm
References
1. Durán, N; Menck, C. F. M; Crit. Rev. Microbiol. 2001, 27, 201.
2. Durán, N.; Justo, G. Z.; Ferreira, C. V.; Melo, P. S.; Cordi, L.;
Martins, D.; Biotechnol. Appl. Biochem. 2007, 48, 127.
3. Rettori, D.; Durán, N.; World J. Microbiol. Biotechnol. 1998,
14, 685.
3
is similar to the spectrum of violacein. As expected, the
concentration profile of this compound increases with
reaction time.
4
. Tobie, W. C.; J. Bacteriol. 1934, 29, 223.
5. DeMoss, R. D.; Evans, N. R.; J. Bacteriol. 1959, 78, 583.
. DeMoss, R. D.; Evans, N. R.; J. Bacteriol. 1960, 79, 729.
Conclusion
6
The use of the multi-wavelength fluorescence
spectroscopy and PARAFAC was introduced as a new
approach for obtaining mechanistic information about the
biosynthesis of fluorescent natural products. Violacein
biosynthesis is used as an example in which six fluorescent
compounds were detected and their concentration and
spectral profiles were resolved by this methodology.
Tryptophan (identified by comparison to emission and
excitation spectra) is consumed during the bioprocess,
corroborating the mechanism presented in Figure 2, in
which this compound is the precursor molecule in violacein
biosynthesis.Additionally, the final product of this pathway,
the violacein molecule, also was identified by means of its
concentration and spectral profiles.
Unfortunately, the identification of other fluorophores
was not possible by spectra comparison due the lack of a
database of fluorescent natural products. This critical step
highlights the necessity of the improvement of databases to
aid the type of analysis proposed herein, where a complex
mechanism could be elucidated by simpler methodology
than the traditional methods. Thus, it is believed that
the dissemination of this methodology is the first step
in its consolidation. Future efforts are being conducted
to try identifying these compounds using techniques of
separation and structural elucidation.
7. Hoshino, T.; Kondo, T;. Uchiyama, T.; Ogasawara, N.; Agric.
Biol. Chem. 1987, 51, 965.
8. Hoshino, T.; Takano, T.; Hori, S.; Ogasawara, N.; Agric. Biol.
Chem. 1987, 51, 2733.
9. Hoshino, T.; Ogasawara, N.; Agric. Biol. Chem. 1990, 54, 2339.
10. Pemberton, J. M.;Vicent, K. M.; Penfold, R. J.; Curr. Microbiol.
1991, 22, 355.
11. Hoshino, T.; Kojima,Y.; Kayashi, T.; Uchiyama, T.; Kaneko, K.;
Biosci. Biotechol., Biochem. 1993, 57, 775.
12. Hoshino, T.; Hayashi, T.; Odajima, T.; J. Chem. Soc., Perkin.
Trans. 1995, 1, 1565.
13. Hoshino, T.;Yamamoto, M.; Biosci. Biotechnol., Biochem. 1997,
61, 2134.
14. Ruhul Momen, A. Z. M.; Hoshino, T.; Biosci. Biotechnol.,
Biochem. 2000, 64, 539.
15. August, P. R.; Grossman, T. H.; Minor, C.; Draper, M. P.;
MacNeil, I.A.; Pemberton, J. M.; Call, K. M.; Holt, D.; Osburne,
M. S.; J. Mol. Microbiol. Biotechnol. 2000, 2, 513.
16. Howard-Jones,A. R.;Walsh, C. T.; Biochemistry 2005, 44, 15652.
17. Sánchez, C.; Braña, A. F.; Méndez, C.; Salas, J. A.;
ChemBioChem 2006, 7, 1231.
18. Balibar, C. J.; Walsh, C. T.; Biochemistry 2006, 45, 15444.
19. Shinoda, K.; Hasegawa, T.; Sato, H.; Shinozaki, M.;
Kuramoto, H.; Takamiya, Y.; Sato, T.; Nikaidou, N.;
Watanabe, T.; Hoshino, T.; Chem. Commun. 2007, 40, 4140.